2017
DOI: 10.1177/1074248417715003
|View full text |Cite
|
Sign up to set email alerts
|

Remote Ischemic Conditioning

Abstract: Although remote ischemic conditioning promises significant benefit to patients with a variety of acute and chronic illnesses, development of automated, clinically applicable devices has been slow. At least 3 small companies have launched efforts to develop useful tools intended for sale in European and North American markets. The market challenges and opportunities linked to the development of a cost-effective, reliable, and clinically effective device for the application of remote ischemic conditioning are pr… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2017
2017
2019
2019

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 21 publications
0
1
0
Order By: Relevance
“…Our primary objective is to examine the duration of the RIC procedure administered in acute chest pain patients with an automated device initiated during ambulance transport. Since an automated device eliminates the need for dedicated personnel to perform manual cuff inflations [10, 25, 26] and based on a prior feasibility study [24], we hypothesize 4 cycles of RIC will be completed in at least 80% of patients having the procedure initiated. Further, we feel 80% is a reasonable lower bound to optimal RIC completion for a full-scale trial.…”
Section: Introductionmentioning
confidence: 99%
“…Our primary objective is to examine the duration of the RIC procedure administered in acute chest pain patients with an automated device initiated during ambulance transport. Since an automated device eliminates the need for dedicated personnel to perform manual cuff inflations [10, 25, 26] and based on a prior feasibility study [24], we hypothesize 4 cycles of RIC will be completed in at least 80% of patients having the procedure initiated. Further, we feel 80% is a reasonable lower bound to optimal RIC completion for a full-scale trial.…”
Section: Introductionmentioning
confidence: 99%